HANNAH LACOMBE: Open Payments
NPI 1679295851 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 27 payments from 12 companies in 2025. Trend: 2023 $601 · 2024 $367 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $210 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| MILLICENT US INC | 4 | $72 |
| Amgen Inc. | 2 | $40 |
| Hologic Sales and Service, LLC | 1 | $36 |
| Astellas Pharma US Inc | 2 | $29 |
| Sage Therapeutics, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: QULIPTA, MYFEMBREE, UBRELVY, FEMLYV, EVENITY, MYOSURE TISSUE REMOVAL DEVICE, Veozah, ZURZUVAE.
Industry payments across LA — which companies pay providers there.
